Gene Query: PPWD1

Dataset Description Geneva Score
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 17.0
RNA sequencing of matched nephrectomy samples [RNA-seq] 17.0
Identification of transcription start sites for human A549 cell line using ReCappable-seq 13.29
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 12.99
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 12.99
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 12.97
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 12.83
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 11.05
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 9.65
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 8.73
TOP2B disturbed the quality of human oocytes with advanced maternal age 8.14
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 7.81
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 7.8
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 7.66
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 7.65
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 7.41
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 7.37
Human cell line and subcutaneous tumor 7.29
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 7.19
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 7.15
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 7.12
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 6.99
Comprehensive comparative analysis of 5’ end RNA sequencing methods 6.88
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 6.84
ETV7 and interferon response 6.82
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 6.82
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 6.78
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 6.78
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 6.73
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 6.66
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 6.63
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 6.57
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 6.23
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 6.11
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 5.9
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 5.85
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 5.82
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 5.7
Genome-wide analysis of the Integrator complex 5.56
Genome-wide analysis of the Integrator complex (HTS) 5.56
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 5.53
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 5.47
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 5.37
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 5.36
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 5.27
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 5.27
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 5.25
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 5.19
Transcriptome analysis of Zika infected neural stem cells 5.17
Zika infected neural stem cells 5.17
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.99
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 4.91
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 4.9
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 4.86
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 4.81
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.79
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 4.72
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 4.72
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.71
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 4.7
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 4.7
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 4.56
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 4.52
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 4.51
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 4.51
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 4.48
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 4.48
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 4.48
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 4.47
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 4.45
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 4.45
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 4.38
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 4.38
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 4.36
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 4.33
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 4.32
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 4.31
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 4.31
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 4.31
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 4.3
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 4.23
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 4.23
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 4.19
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.19
Primary human trophoblast from term placenta 4.19
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 4.13
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 4.12
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 4.12
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 4.12
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 4.07
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 4.07
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 4.03
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 4.0
TCF7L1 knockdown in pancreatic cancer 3.99
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 3.99
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 3.98
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 3.98
Single-cell analysis of adult human ovary using 10X genomics 3.98
DART-seq: an antibody-free method for global m6A detection 3.94
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 3.92
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 3.92
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 3.9
Global Mapping of Human RNA-RNA Interactions 3.88
CircRNAome diversity in human mature B-cells, T-cells and monocytes 3.86
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 3.81
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 3.8
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.77
Gene expression profiling of leukemia cells following asparagine depletion 3.75
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 3.74
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 3.72
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 3.7
Integrating single-cell transcriptomic data across different conditions, technologies, and species 3.68
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 3.67
Identification of global regulators of T-helper cell lineage specification 3.66
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 3.66
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.66
Single-cell analysis of human kidney organoids 3.66
LncRNA expression profiling of ischemic stroke patients 3.64
CROP-Seq in Primary Human T Cells 3.63
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 3.61
MOF acetyl transferase regulates transcription and respiration in mitochondria 3.59
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 3.53
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.49
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 3.48
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 3.48
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 3.48
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 3.48
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 3.47
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 3.44
Mutational landscape of splicing genes and functional consequences across 33 cancer types 3.44
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 3.37
RNA-seq of resting and activated CD4+ T cells +-JQ1 3.36
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.36
Regulation of protein translation during mitosis 3.33
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 3.31
LNCaP treated with iBET 3.3
An optimization system for isolating and sequencing of single human colon cancer cells 3.3
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 3.3
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 3.29
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.28
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 3.25
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 3.24
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 3.24
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 3.24
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 3.23
mRNA expression profile of Lymphocytes 3.22
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 3.21
Human Treg NaCl stimulation 3.2
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 3.19
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 3.18
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 3.18
Total RNA-seq in ALL-SIL upon TLX1 knockdown 3.17
FBXW7 modulates stress response by post-translational modification of HSF1 3.17
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 3.17
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 3.16
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 3.15
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 3.15
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 3.14
Gene expression analysis of the impact of TDP-43 knockout in human cells. 3.13
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 3.11
RNA expression following TMPRSS11B overexpression or depletion 3.1
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.09
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.09
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 3.08
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 3.07
Expression by CD133+ cells isolated from the adult human exocrine pancreas 3.06
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 3.06
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 3.06
Fibroblasts in cholesteatoma activate osteoclasts. 3.04
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 3.04
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 3.04
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.03
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 3.03
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 3.02
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 2.98
Oncogenic MYC induces a dependency on the spliceosome in human cancer 2.98
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 2.91
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 2.9
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 2.9
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 2.88
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 2.87
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.87
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 2.87
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 2.86
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 2.85
Seletive inhibition of CDK9 in DLBCL cell lines 2.84
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.84
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 2.79
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 2.79
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 2.77
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 2.75
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 2.75
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.75
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.74
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 2.73
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 2.72
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.72
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 2.66
SNHG5 siRNA knock down in HCT116 cells 2.66
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 2.62
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 2.6
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 2.6
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.6
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 2.58
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 2.58
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 2.57
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 2.55
Gene expression changes caused by KRAS in MCF-10A 2.54
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 2.54
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.52
The Genetic Landscape of Diamond-Blackfan Anemia 2.51
Effect of drugs on transcriptomic profiles 2.5
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 2.5
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 2.5
Co-regulation of splicing by Rbfox1 and hnRNP M 2.47
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 2.47
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.46
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.46
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 2.45
Proliferation-correlated expression 2.44
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 2.44
MAIT cell RNA sequencing 2.44
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 2.42
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.4
Gene expression profile in breast cancer cells 2.4
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 2.4
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 2.39
Measure transcript integrity using RNA-seq data 2.37
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 2.36
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 2.36
Analysis of transcriptional regulation by Myt1 and Myt1l 2.35
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 2.34
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 2.34
Hijacking of stress response machinery by oncogenes in acute leukaemia 2.33
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 2.33
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.32
Stem and effector CD8 T-cells from human cancers 2.31
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 2.3
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.29
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.29
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 2.29
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.28
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.24
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.23
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 2.21
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 2.17
Transcriptome of human ILC2s; primary vs IL-1b-primed 2.15
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.15
RNA seq with AML (NB4) cells upon FTO inhibition 2.13
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 2.12
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 2.12
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.1
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 2.1
RNA-Seq from human ILC transitional populations 2.09
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 2.09
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 2.08
Endothelial gene expression analysis 2.05
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 2.05
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 2.04
RNA-seq analyisis of PUM2 knockout cells 2.04
Transcriptional profiling of microglia; current state of the art and future perspectives 2.03
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 2.02
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 2.02
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 2.01
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.97
Gene expression signatures of innate lymphoid cells from human blood 1.96
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.95
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 1.94
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 1.94
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 1.91
N6-methyladenine DNA Modification in Glioblastoma 1.91
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 1.88
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 1.88
Global transcriptome analysis of HAP1 cells 1.86
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 1.83
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.83
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.8
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.8
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.77
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.76
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.76
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.76
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.75
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.73
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.72
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.72
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 1.71
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 1.71
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 1.68
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 1.68
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 1.68
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.67
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.67
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 1.67
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.66
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 1.65
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.64
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.63
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.63
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 1.61
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.61
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.59
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.59
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.59
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 1.58
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 1.56
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.55
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.52
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 1.5
Transcriptome-wide response to synthetic chromatin protein PcTF 1.5
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 1.49
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.49
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.48
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 1.46
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.46
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 1.45
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 1.45
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.44
Biological effect of chronic mistranslation in mammalian cells 1.41
IMP3 regulated gene expression in breast cancer cells 1.4
SLIGRL-induced gene expression changes in NHEK cells 1.38
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.37
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.37
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 1.36
Dysregulated immune system networks in war veterans with PTSD 1.35
The contribution of Alu exons to the human proteome 1.35
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.32
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 1.32
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 1.32
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.28
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 1.28
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 1.26
RNA-seq analysis of control and Myc-induced U2OS cells 1.25
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 1.24
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.24
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 1.23
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.22
Role of FGFR1 in neuronal devlopment 1.18
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 1.13
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 1.12
Functional significance of the HIV-1 Tat signature amino acid residues 1.12
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 1.12
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 1.11
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.1
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.07
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 1.05
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.05
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.03
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.03
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.01
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 1.01
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 1.0
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 1.0
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.99
K562 polyA RNA-Seq 0.98
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.96
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 0.94
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 0.94
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.91
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.91
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.9
Effect of PRDM11 depletion in U2932 cells 0.89
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 0.87
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 0.87
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.87
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.86
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.86
Identification of a LIF-responsive replication-competent human β cell 0.86
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.85
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.85
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 0.83
MicroRNA-125a-5p overexpression in human macrophages 0.82
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.8
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.8
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.79
Ribosomal protein RPL26 is the principal target of UFMylation 0.79
Human Treg IFNg/IL-10 subpopulations 0.79
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.79
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 0.78
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.76
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 0.76
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.76
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.75
quanTIseq: quantifying immune contexture of human tumors 0.75
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.74
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 0.74
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.74
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.7
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.7
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.69
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.68
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.68
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.67
Gene expression analysis upon mtDNA depletion 0.67
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.65
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.64
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.64
High-resolution comparative analysis of great ape genomes 0.63
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.62
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.62
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.62
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.62
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.62
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.62
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 0.58
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 0.58
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.58
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.57
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.57
Hypoxic transcriptome of SQ20B human head and neck cancer cells 0.57
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.55
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 0.55
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.55
RNA-seq data 0.52
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.51
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 0.5
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 0.5
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.5
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.49
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.49
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.46
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.46
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.46
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.46
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.46
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 0.45
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.45
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.45
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.44
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.44
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.44
Total RNA-Seq data from leukemic patients with complex structural variants 0.43
High-throughput sequencing of PROMPT-enriched samples. 0.42
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.42
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.41
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.41
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.41
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.4
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 0.4
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.4
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.39
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 0.39
RNA-Seq of the corpus callosum from 12 individuals 0.37
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.37
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.35
Human Treg IL-12 stimulation 0.35
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.35
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.34
Transcriptional landscape changes during human embryonic stem cell derivation 0.34
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.32
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.32
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 0.32
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.32
Aging-associated patterns in the expression of human endogenous retroviruses 0.31
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.31
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.31
Transcriptome-wide modulation of splicing by the exon junction complex 0.3
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.3
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.3
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.3
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 0.28
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.28
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.28
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.27
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.26
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 0.24
The transcriptome and chromatin accessbility landscape of mammalian germline 0.24
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.24
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.23
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.22
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.22
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.2
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.2
siRNA-mediated knockdown 0.19
HBEC-shp53-PCHD7 0.18
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 0.18
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.18
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.16
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.16
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.15
Modulation of nonsense-mediated decay by rapamycin 0.13
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.13
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.12
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.09
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.07
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.07
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.07
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.06
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.05
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.05
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.04
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.04
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.03
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.03
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.02
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.01
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.01
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.01
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation